Co-Authors
This is a "connection" page, showing publications co-authored by Carlo Mazzatenta and Giuseppe Argenziano.
Connection Strength
0.643
-
Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle? J Eur Acad Dermatol Venereol. 2021 09; 35(9):e543-e545.
Score: 0.237
-
Late-onset pustular skin eruption in a healthy neonate born from COVID-positive mother: a coincidence or a new skin sign of the infection? J Eur Acad Dermatol Venereol. 2021 Dec; 35(12):e850-e852.
Score: 0.060
-
Contemporary occurrence of Chilblain-like lesions and Pityriasis rosea during the COVID-19 pandemic. J Eur Acad Dermatol Venereol. 2021 Oct; 35(10):e619-e620.
Score: 0.059
-
BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2. J Eur Acad Dermatol Venereol. 2021 Aug; 35(8):e493-e494.
Score: 0.059
-
Chilblain-like lesions and COVID-19: second wave, second outbreak. J Eur Acad Dermatol Venereol. 2021 May; 35(5):e316-e318.
Score: 0.058
-
Chilblain-Like Lesions during COVID-19 Pandemic: The State of the Art. Life (Basel). 2021 Jan 02; 11(1).
Score: 0.058
-
Dermoscopy of chilblain-like lesions during the COVID-19 outbreak: A multicenter study on 10 patients. J Am Acad Dermatol. 2020 12; 83(6):1749-1751.
Score: 0.057
-
Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients. J Eur Acad Dermatol Venereol. 2020 Jul; 34(7):e291-e293.
Score: 0.055